Cambrex Corp.


Over the past 29 years, Cambrex Corporation has strategically ac­quired complementary resources and technologies to achieve growth and success in manufacturing small molecule active pharmaceutical ingredients (APIs). Working with multinational and small or emerging pharmas, Cambrex excels in difficult areas of chemistry and has the experience to take customers through development, scale-up and the manufacture of commercial volumes of branded and generic bulk APIs.


Cambrex Corp.